2.0
Apr 30, 2018
Anonymous employee
Former employee, more than 8 years
Cambridge, MA
Recommend
CEO approval
Business outlook
Pros
Unlimited career options and good growth potential in most areas, you learn a ton, they are a strong leader in most areas they conduct research in, especially clinical trial and real world evidence studies.
Cons
Benefits and culture on a serious downhill slide since merger with IMS (from legacy Q perspective). Different areas of the company that overlap in services compete with each other rather than collaborate and this seems to be encouraged. All male leaders (very rare exceptions) at the top in an organization that is probably more than half female in ranks. Respect for medical and scientific expertise over selling data has slipped.